{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-037450","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2026-09-23T21:08:31+00:00","discovered_at":"2026-09-23T21:10:00.316608+00:00","generated_at":"2026-09-23T21:10:14.880890+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bio-Techne shareholders approve Merck KGaA acquisition; HSR waiting period expired","bullets":["Merger Agreement approved: 121,929,544 for, 1,208,817 against, 30,610 abstaining.","Non-binding advisory compensation vote failed: 25,912,275 for, 96,412,306 against.","HSR waiting period expired Sept 18, 2026; closing expected late 2026/early 2027.","CEO Kim Kelderman cites 'strong support' and near-term cash value for shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-037450","json":"https://secwatch.observer/filing/0001140361-26-037450.json","markdown":"https://secwatch.observer/filing/0001140361-26-037450.md","text":"https://secwatch.observer/filing/0001140361-26-037450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000114036126037450/0001140361-26-037450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000114036126037450/ef20082601_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-23T21:10:14.880890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}